Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: Therapeutic implications

Molecular Cancer Therapeutics

Volumn 6, Issue 1, 2007, Pages 286-298

  Venè, Roberta ^a   Arena, Giuseppe ^a   Poggi, Alessandro ^a   D'Arrigo, Cristina ^b   Mormino, Michele ^b   Noonan, Douglas M ^c   Albini, Adriana ^d   Tosetti, Francesca ^a  

^a National Cancer Research Institute IST   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CATHEPSIN D; CYTOCHROME C; DNA FRAGMENT; FENRETINIDE; LACTATE DEHYDROGENASE; PEPSTATIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C;

ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL ENERGY; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DRUG CYTOTOXICITY; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; KAPOSI SARCOMA; LYSOSOME; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RETINOBLASTOMA;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; BENZYL COMPOUNDS; CASPASE 3; CATHEPSIN D; CELL DEATH; CELL SURVIVAL; CYTOCHROMES C; CYTOSOL; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; HYDROCARBONS, FLUORINATED; INSULIN-LIKE GROWTH FACTOR I; LYSOSOMES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RETINOBLASTOMA; TIME FACTORS; TRETINOIN;

EID: 33846805629     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0346     Document Type: Article

References (49)

1. Swanson BN, Zaharevitz DW, Sporn MB. Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats. Drug Metab Dispos 1980;8: 168-72.
2. Veronesi U, Mariani L, Decensi A, et al. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol 2006;4:4.
3. Suzuki S, Higuchi M, Proske RJ, et al. Implication of mitochondria-derived reactive oxygen species, cytochrome c and caspase-3 in N-(hydroxyphenil)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 1999; 18:6380-7.
4. Sun SY, Li W, Yue P, et al. Mediation of N-(4-hydoxyphenyl)retina-mide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 1999;59:2493-8.
5. DiPietrantonio AM, Hsieh TC, Juan G, et al. Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation. Cancer Res 2000;60: 4331-5.
6. Hail NJ, Lotan R. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide. J Biol Chem 2001;276:45614-21.
7. Boya P, Morales MC, Gonzalez-Polo RA, et al. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene 2003;22:6220-30.
8. Lovat PE, Di Sano F, Corazzari M, et al. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. J Natl Cancer Inst 2004;96:1288-99.
9. Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines. J Natl Cancer Inst 1999; 91:1138-46.
10. O'Donnell PH, Guo WX, Reynolds CP, Maurer BJ. N-(4-Hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. Leukemia 2002; 16:902-10.
11. Erdreich-Epstein A, Tran L, Bowman N, et al. Ceramide signaling in fenretinide-induced enclothelial cell apoptosis. J Biol Chem 2002;277: 49531-7.
12. Chen YR, Zhou G, Tan TH. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide. Mol Pharmacol 1999;56:1271-9.
13. Appierto V, Villani MG, Cavadini E, et al. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. Cell Death Differ 2004; 11:270-9.
14. Lovat PE, Oliverio S, Corazzari M, et al. Induction of GADD 153 and Bak: novel molecular targets of fenretinicle-induced apoptosis of neuro- blastoma. Cancer Lett 2003; 197:157-63.
15. Cuello M, Coats AO, Darko I, et al. N-(4-Hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines. Cell Death Differ 2004; 11: 527-41.
16. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer 2005;5:91-101.
17. DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol 2000; 10:255-69.
18. Puduvalli VK, Li JT, Chen L, McCutcheon IE. Induction of apoptosis in primary meningioma cultures by fenretinide. Cancer Res 2005;65: 1547-53.
19. Puduvalli VK, Yung WK, Hess KR, et al. Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. J Clin Oncol 2004;22:4282-9.
20. Tosetti F, Vene R, Arena G, et al. N-(4-Hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death. Mol Pharmacol 2003;63:565-73.
21. Mathiasen IS, Jaattela M. Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2002;8:212-20.
22. Garaventa A, Luksch R, Lo Piccolo MS, et al. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 2003;9:2032-9.
23. Fassina G, Aluigi M, Gentleman S, et al. The cAMP analog 8-Cl-cAMP inhibits growth, induces differentiation and apoptosis in retinoblastoma cells. Int J Cancer 1997;72:1088-94.
24. Bottenstein J. Advances in vertebrate cell culture methods. Science 1988;239:G42, G8.
25. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
26. Ono K, Kim SO, Han J. Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor α-induced cell death. Mol Cell Biol 2003;23:665-76.
27. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 1999;442:117-21.
28. Kagedal K, Johansson U, Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 2001;15:1592-4.
29. Raymond MA, Mollica L, Vigneault N, et al. Blockade of the apoptotic machinery by cyclosporin A redirects cell death toward necrosis in arterial endothelial cells: regulation by reactive oxygen species and cathepsin D. FASEB J 2003; 17:515-7. Epub 2003 Jan 2.
30. Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004;200:425-35.
31. Persson HL, Yu Z, Tirosh O, Eaton JW, Brunk UT. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic Biol Med 2003;34:1295-305.
32. Doulias PT, Christoforiclis S, Brunk UT, Galaris D. Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest. Free Radic Biol Med 2003;35:719-28.
33. Jemmerson R, LaPlante B, Treeful A. Release of intact, monomeric cytochrome c from apoptotic and necrotic cells. Cell Death Differ 2002;9: 538-48.
34. Nicotera P, Leist M, Manzo L. Neuronal cell death: a demise with different shapes. Trends Pharmacol Sci 1999;20:46-51.
35. Zaman K, Ryu H, Hall D, et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inclucible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (waf1/cip1), and erythropoietin. J Neurosci 1999; 19:9821-30.
36. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid β pepticle. Neuron 2003;39:43-56.
37. Oexle H, Gnaiger E, Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta 1999; 1413:99-107.
38. Perl A, Gergely P, Jr., Nagy G, Koncz A, Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 2004;25:360-7.
39. Hahn-Windgassen A, Nogueira V, Chen CC, et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005;280:32081-9. Epub 2005 Jul 15.
40. Miyamoto S, Howes AL, Adams JW, Dom GW II, Brown JH. Ca2+ dysregulation induces mitochondrial depolarization and apoptosis: role of Na+/Ca2+ exchanger and AKT. J Biol Chem 2005;280:38505-12. Epub 2005 Aug 1.
41. Seigel GM, Chiu L, Paxhia A. Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. Mol Vis 2000;6:157-63.
42. Zdolsek J, Zhang H, Roberg K, Brunk U. H2O2-mediated damage to lysosomal membranes of J-774 cells. Free Radic Res Commun 1993;18: 71-85.
43. Cirman T, Oresic K, Mazovec GD, et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004;279:3578-87. Epub 2003 Oct 27.
44. Johansson AC, Steen H, Ollinger K, Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003; 10: 1253-9.
45. Jaattela M, Cande C, Kroemer G. Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ 2004; 11: 135-6.
46. Antunes F, Cadenas E, Brunk UT. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochem J 2001;356:549-55.
47. Waterhouse NJ, Goldstein JC, von Ahsen O, et al. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 2001; 153:319-28.
48. Zang Y, Beard RL, Chandraratna RA, Kang JX. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ 2001;8:477-85.
49. Sporn MB, Liby KT. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat Clin Pract Oncol 2005;2:518-25.